Xiaosong Jiang

Dr. Xiaosong Jiang is committed to innovative research in liver diseases, with a particular focus on hepatic ischemia/reperfusion injury and liver fibrosis. As an Associate Adjunct Professor at the UC Davis School of Veterinary Medicine, he leads groundbreaking studies as the Principal Investigator on projects funded by the National Institutes of Health (NIH). His work on Galectin-3 in Primary Biliary Cirrhosis and Liver Fibrosis is paving the way for new insights into these complex conditions. Dr. Jiang's research is characterized by a deep understanding of the molecular mechanisms that drive liver pathologies. His extensive publication record reflects his dedication to uncovering potential therapeutic interventions for liver diseases. His work not only advances scientific knowledge but also has significant implications for improving patient outcomes in veterinary and human medicine. With a strong background in nonalcoholic fatty liver disease, Dr. Jiang's contributions to the field are widely recognized. His research endeavors are aimed at translating laboratory findings into clinical applications, thereby bridging the gap between basic science and practical treatment solutions. Through his commitment to excellence in research and education, Dr. Jiang continues to inspire the next generation of scientists and veterinarians.